Q14764 (MVP_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 121.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Major vault protein Short name=MVP Alternative name(s): Lung resistance-related protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 893 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates INFG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases. Ref.9 Ref.11 Ref.12 |
| Subunit structure | The vault ribonucleoprotein particle is a huge (400 A x 670 A) cage structure of 12.9 MDa. It consists of a dimer of half-vaults, with each half-vault comprising 39 identical major vault protein (MVP) chains, PARP4 and one or more vault RNAs (vRNAs). Interacts with TEP1. Interacts with PTEN and activated MAPK1. The phosphorylated protein interacts with the SH2 domains of PTPN11 and SRC. Interacts with APEX1. May interact with ZNF540. Ref.8 Ref.9 Ref.10 Ref.11 Ref.13 Ref.16 |
| Subcellular location | Cytoplasm. Nucleus › nuclear pore complex. Note: 5% found in the nuclear pore complex. Translocates from the nucleus to the cytoplasm upon EGF treatment. Ref.9 Ref.11 |
| Tissue specificity | Present in most normal tissues. Higher expression observed in epithelial cells with secretory and excretory functions, as well as in cells chronically exposed to xenobiotics, such as bronchial cells and cells lining the intestine. Overexpressed in many multidrug-resistant cancer cells. |
| Induction | Up-regulated by IFNG/IFN-gamma. Ref.12 |
| Domain | MVP 3 mediates interaction with PTEN. MVP 4 mediates interaction with PARP4. |
| Post-translational modification | Phosphorylated on Tyr residues after EGF stimulation. Ref.9 Ref.11 |
| Sequence similarities | Contains 9 MVP (vault) repeats. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.6 | |||||||||||||||||||||||
| Chain | 2 – 893 | 892 | Major vault protein | PRO_0000158980 | ||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||
| Repeat | 2 – 56 | 55 | MVP 1 | |||||||||||||||||||||||
| Repeat | 57 – 111 | 55 | MVP 2 | |||||||||||||||||||||||
| Repeat | 112 – 164 | 53 | MVP 3 | |||||||||||||||||||||||
| Repeat | 165 – 217 | 53 | MVP 4 | |||||||||||||||||||||||
| Repeat | 218 – 272 | 55 | MVP 5 | |||||||||||||||||||||||
| Repeat | 273 – 323 | 51 | MVP 6 | |||||||||||||||||||||||
| Repeat | 324 – 379 | 56 | MVP 7 | |||||||||||||||||||||||
| Repeat | 380 – 457 | 78 | MVP 8 | |||||||||||||||||||||||
| Repeat | 458 – 520 | 63 | MVP 9 | |||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.6 | |||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||
| Natural variant | 635 | 1 | V → I. Corresponds to variant rs35916172 [ dbSNP | Ensembl ]. | VAR_050179 | ||||||||||||||||||||||
| Natural variant | 651 | 1 | R → Q. Corresponds to variant rs3764944 [ dbSNP | Ensembl ]. | VAR_050180 | ||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||
| Beta strand | 120 – 125 | 6 | ||||||||||||||||||||||||
| Beta strand | 137 – 139 | 3 | ||||||||||||||||||||||||
| Beta strand | 141 – 147 | 7 | ||||||||||||||||||||||||
| Helix | 148 – 150 | 3 | ||||||||||||||||||||||||
| Beta strand | 157 – 163 | 7 | ||||||||||||||||||||||||
| Beta strand | 170 – 181 | 12 | ||||||||||||||||||||||||
| Beta strand | 185 – 187 | 3 | ||||||||||||||||||||||||
| Beta strand | 195 – 198 | 4 | ||||||||||||||||||||||||
| Beta strand | 208 – 217 | 10 | ||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The drug resistance-related protein LRP is the human major vault protein." Scheffer G.L., Wijngaard P.L.J., Flens M.J., Izquierdo M.A., Slovak M.L., Pinedo H.M., Meijer C.J.L.M., Clevers H.C., Scheper R.J. Nat. Med. 1:578-582(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | Scheffer G.L. Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION TO C-TERMINUS. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Eye. |
| [4] | "Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter." Lange C., Walther W., Schwabe H., Stein U. Biochem. Biophys. Res. Commun. 278:125-133(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-169. |
| [5] | "A small upstream open reading frame causes inhibition of human major vault protein expression from a ubiquitous mRNA splice variant." Holzmann K., Ambrosch I., Elbling L., Micksche M., Berger W. FEBS Lett. 494:99-104(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1-65. Tissue: Lung cancer. |
| [6] | Quadroni M., Potts A., Barblan J., Bienvenut W.V. Submitted (JAN-2005) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-9; 68-82 AND 462-474, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, MASS SPECTROMETRY. Tissue: Melanoma. |
| [7] | "Vaults and telomerase share a common subunit, TEP1." Kickhoefer V.A., Stephen A.G., Harrington L., Robinson M.O., Rome L.H. J. Biol. Chem. 274:32712-32717(1999) [PubMed] [Europe PMC] [Abstract] Cited for: ASSOCIATION WITH TEP1. |
| [8] | "PTEN associates with the vault particles in HeLa cells." Yu Z., Fotouhi-Ardakani N., Wu L., Maoui M., Wang S., Banville D., Shen S.-H. J. Biol. Chem. 277:40247-40252(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PTEN. |
| [9] | "The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling." Kolli S., Zito C.I., Mossink M.H., Wiemer E.A.C., Bennett A.M. J. Biol. Chem. 279:29374-29385(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT TYROSINE RESIDUES, MASS SPECTROMETRY, INTERACTION WITH PTPN11, SUBCELLULAR LOCATION, FUNCTION. |
| [10] | "A novel human zinc finger protein ZNF540 interacts with MVP and inhibits transcriptional activities of the ERK signal pathway." Xiang Z., Yuan W., Luo N., Wang Y., Tan K., Deng Y., Zhou X., Zhu C., Li Y., Liu M., Wu X., Li Y. Biochem. Biophys. Res. Commun. 347:288-296(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ZNF540. |
| [11] | "Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling." Kim E., Lee S., Mian M.F., Yun S.U., Song M., Yi K.-S., Ryu S.H., Suh P.-G. FEBS J. 273:793-804(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH SRC, TYROSINE PHOSPHORYLATION, SUBCELLULAR LOCATION, MASS SPECTROMETRY. |
| [12] | "The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals." Steiner E., Holzmann K., Pirker C., Elbling L., Micksche M., Sutterluety H., Berger W. J. Cell Sci. 119:459-469(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION, FUNCTION. |
| [13] | "Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1." Chattopadhyay R., Das S., Maiti A.K., Boldogh I., Xie J., Hazra T.K., Kohno K., Mitra S., Bhakat K.K. Mol. Cell. Biol. 28:7066-7080(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH APEX1. |
| [14] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [15] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [16] | "Solution structure of a two-repeat fragment of major vault protein." Kozlov G., Vavelyuk O., Minailiuc O., Banville D., Gehring K., Ekiel I. J. Mol. Biol. 356:444-452(2006) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 113-221, INTERACTION WITH PARP4. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X79882 mRNA. Translation: CAA56256.2. BC015623 mRNA. Translation: AAH15623.1. AJ238512 AJ238518 Genomic DNA. Translation: CAB55354.1.AJ238519 AJ238518 Genomic DNA. Translation: CAB55355.1.AJ291365 Genomic DNA. Translation: CAC35313.1. AJ291366 mRNA. Translation: CAC35314.1. AJ291367 mRNA. Translation: CAC35316.1. | ||||||||||||
| IPI | IPI00000105. | ||||||||||||
| PIR | S57723. | ||||||||||||
| RefSeq | NP_005106.2. NM_005115.4. NP_059447.2. NM_017458.3. | ||||||||||||
| UniGene | Hs.632177. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q14764. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q14764. 14 interactions. | ||||||||||||
| MINT | MINT-5004583. | ||||||||||||
| STRING | 9606.ENSP00000349977. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q14764. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 21542417. | ||||||||||||
2D gel databases | |||||||||||||
| OGP | Q14764. | ||||||||||||
| REPRODUCTION-2DPAGE | IPI00000105. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q14764. | ||||||||||||
| PeptideAtlas | Q14764. | ||||||||||||
| PRIDE | Q14764. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 9961. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000357402; ENSP00000349977; ENSG00000013364. ENST00000395353; ENSP00000378760; ENSG00000013364. | ||||||||||||
| GeneID | 9961. | ||||||||||||
| KEGG | hsa:9961. | ||||||||||||
| UCSC | uc002dui.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 9961. | ||||||||||||
| GeneCards | GC16P029831. | ||||||||||||
| HGNC | HGNC:7531. MVP. | ||||||||||||
| HPA | CAB002752. CAB022717. HPA002321. | ||||||||||||
| MIM | 605088. gene. | ||||||||||||
| neXtProt | NX_Q14764. | ||||||||||||
| PharmGKB | PA31332. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG70525. | ||||||||||||
| HOGENOM | HOG000255109. | ||||||||||||
| HOVERGEN | HBG003499. | ||||||||||||
| InParanoid | Q14764. | ||||||||||||
| OMA | QDPLADR. | ||||||||||||
| OrthoDB | EOG4GQQ48. | ||||||||||||
| PhylomeDB | Q14764. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| SignaLink | Q14764. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q14764. | ||||||||||||
| Bgee | Q14764. | ||||||||||||
| CleanEx | HS_MVP. | ||||||||||||
| Genevestigator | Q14764. | ||||||||||||
| GermOnline | ENSG00000013364. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR021870. MVP_shoulder. IPR002499. Vault_N. [Graphical view] | ||||||||||||
| Pfam | PF11978. MVP_shoulder. 1 hit. PF01505. Vault. 5 hits. [Graphical view] | ||||||||||||
| PROSITE | PS51224. MVP. 8 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | Q14764. | ||||||||||||
| GenomeRNAi | 9961. | ||||||||||||
| NextBio | 37586. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | MVP_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q14764 Secondary accession number(s): Q96BG4 Q9UBD1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
